FDX2 and ISCU Gene Variations Lead to Rhabdomyolysis With Distinct Severity and Iron Regulation
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received February 23, 2021
- Accepted in final form October 18, 2021
- First Published January 19, 2022.
Author Disclosures
- Sebastian Montealegre, PhD (sebastianmontealegre{at}gmail.com),
- Elise Lebigot, MD, PhD (elise.lebigot{at}aphp.fr),
- Hugo Debruge, BSc (hugodinio{at}gmail.com),
- Norma Romero, MD, PhD (nb.romero{at}institut-myologie.org),
- Bénédicte Héron, MD (benedicte.heron{at}aphp.fr),
- Pauline Gaignard, MD, PhD (pauline.gaignard{at}aphp.fr),
- Antoine Legendre, MD, PhD (antoine.legendre{at}aphp.fr),
- Apolline Imbard, MD, PhD (apolline.imbard{at}aphp.fr),
- Stéphanie Gobin, PhD (stephanie.gobin{at}aphp.fr),
- Emmanuelle Lacène, BSc (e.lacene{at}institut-myologie.org),
- Patrick Nusbaum, PhD (patrick.nusbaum{at}aphp.fr),
- Arnaud Hubas, PhD (arnaud.hubas{at}aphp.fr),
- Isabelle Desguerre, MD, PhD (isabelle.desguerre{at}aphp.fr),
- Aude Servais, MD, PhD (aude.servais{at}aphp.fr),
- Pascal Laforêt, MD, PhD (pascal.laforet{at}aphp.fr),
- Peter van Endert, MD, PhD (peter.van-endert{at}inserm.fr),
- François Jérome Authier, MD, PhD (fj.authier{at}gmail.com),
- Cyril Gitiaux, MD, PhD (cyril.gitiaux{at}aphp.fr) and
- Pascale de Lonlay, MD, PhD
- Sebastian Montealegre, PhD (sebastianmontealegre{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Elise Lebigot, MD, PhD (elise.lebigot{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Hugo Debruge, BSc (hugodinio{at}gmail.com),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Norma Romero, MD, PhD (nb.romero{at}institut-myologie.org),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Bénédicte Héron, MD (benedicte.heron{at}aphp.fr),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- honoraria for advisory boards from Orchard Therapeutics, Actelion, Shire/Takeda, Orphazyme; - principal investigator for Abeona, Orphazyme, Lysogene, Mallincrodt, Idorsia, JCR Pharmaceuticals, and Chiesi studies; - expert consultant for Lysogene, Takeda and Orphazyme.
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Pauline Gaignard, MD, PhD (pauline.gaignard{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Antoine Legendre, MD, PhD (antoine.legendre{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Apolline Imbard, MD, PhD (apolline.imbard{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Stéphanie Gobin, PhD (stephanie.gobin{at}aphp.fr),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Emmanuelle Lacène, BSc (e.lacene{at}institut-myologie.org),
None
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
None
NONE
NONE
NONE
NONE
NONE
NONE
- Patrick Nusbaum, PhD (patrick.nusbaum{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Arnaud Hubas, PhD (arnaud.hubas{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Isabelle Desguerre, MD, PhD (isabelle.desguerre{at}aphp.fr),
PTC Inc Avexis
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
AFM Association Française contre la Myopathie
NONE
NONE
NONE
NONE
NONE
NONE
- Aude Servais, MD, PhD (aude.servais{at}aphp.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pascal Laforêt, MD, PhD (pascal.laforet{at}aphp.fr),
I was invited to participate to Pompe advisory boards y Sanofi-Genzyme, Amicus therapeutics and Spark Therapeutics
NONE
I received funding for travel and speaker honoraria from Genzyme-Sanofi, Sparks therapeutics and Biogen
I am member of the editorial board of "Revue Neurologique", without compensation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
I received research supports from Genzyme-Sanofi for the French Pompe Registry, and from Valerion Therapeutics to support the Glycogenosis type III registry
NONE
I received fundings from French Glycogenosis Association and AFM (French association against Myopathies)
None
NONE
NONE
NONE
NONE
NONE
NONE
- Peter van Endert, MD, PhD (peter.van-endert{at}inserm.fr),
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Fondation pour la Recherche Médicale (France)
NONE
NONE
NONE
NONE
NONE
NONE
- François Jérome Authier, MD, PhD (fj.authier{at}gmail.com),
None
NONE
None
'Diagnostics'(MDPI)Editor, no Financial compensation
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
Association Francaise contre les Myopathies 5-years grant TRANSLAMUSCLE (2020-25)
NONE
NONE
NONE
NONE
NONE
NONE
- Cyril Gitiaux, MD, PhD (cyril.gitiaux{at}aphp.fr) and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pascale de Lonlay, MD, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- From the Inserm U1151 (S.M., H.D., P.E., P.d.L.), Institut Necker Enfants-Malades, Paris; Reference Center of Inherited Metabolic Diseases (S.M., A.I., A.S., P.d.L.), Necker-Enfants-Malades University Hospital, APHP, Imagine Institute, Paris University, Filière G2M; Biochemistry Laboratory (E. Lebigot, P.G.), Filière G2M, Bicêtre Hospital, APHP Paris Saclay, Le Kremlin Bicêtre; Sorbonne Universié (E. Lacène), UPMC, INSERM UMR974, Center for Research in Myology, Neuromuscular Morphology Unit, Myology Institute, AP-HP, East-Paris Reference Center of Neuromuscular Diseases, GHU Pitié-Salpêtrière; Neurology Unit (N.R., B.H.), Trousseau Hospital, APHP, Filière G2M; M3C-Necker (A.L.), Congenital and Pediatric Cardiology, Hôpital Universitaire Necker-Enfants Malades; Biochemistry Department (A.I.), Necker-Enfants-Malades University Hospital, APHP, Paris University; Genetics Department (S.G.), Necker-Enfants-Malades University Hospital, APHP; Genetics and Molecular Biology (P.N., A.H.), Laboratoire de Culture Cellulaire, Hôpital Cochin, Paris; Reference Center of Neuromuscular Diseases (I.D., C.G.), Necker-Enfants-Malades University Hospital, APHP, Filière Filnemus; Adult Nephrology & Transplantation (A.S.), Necker-Enfants-Malades University Hospital, APHP, Inserm U1163, Imagine Institute, Paris Descartes University; Department of Neurology (P.L.), Raymond-Poincaré Hospital, Garches, and Inserm U1179 Versailles Saint-Quentin-en-Yvelines University, Montigny-le-Bretonneux; and Reference Center for Neuromuscular Disorders (F.J.A., C.G.), Department de Pathologie, Henri Mondor Hospital, APHP, IMRB U955, Faculty of Medicine, Creteil, France.
- Correspondence
Dr. de Lonlay pdelonlay{at}gmail.com
Article usage
Letters: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Related Articles
- No related articles found.